Daily BriefsUnited States

Daily Brief United States: Walmart, Beyond Meat, Apyron, Cloudastructure and more

In today’s briefing:

  • Walmart (WMT US): Unwrapping Nasdaq100 Inclusion Following Listing Transfer
  • Primer: Beyond Meat (BYND US) – Dec 2025
  • How Apyron’s Neurostimulation Solution Breaks the Chronic Pain Barrier
  • CSAI: WTR Small-Cap Spotlight Recap – AI Comes to Video Surveillance; See More, Act Faster


Walmart (WMT US): Unwrapping Nasdaq100 Inclusion Following Listing Transfer

By Dimitris Ioannidis

  • Walmart (WMT US) is now eligible for Nasdaq100 following its listing change from NYSE to Nasdaq on 9 December 2025, marking the largest exchange transfer in history.
  • The listing transfer was completed after the December 2025 annual review cut-off, so Nasdaq100 inclusion is anticipated by December 2026.
  • Forecasted passive fund demand upon inclusion is ~600m shares, $70bn and 25 ADV.

Primer: Beyond Meat (BYND US) – Dec 2025

By αSK

  • Beyond Meat is a pioneer in the plant-based meat industry facing severe financial headwinds, including persistent net losses, negative cash flow, and a high debt burden. The company’s stock has experienced a dramatic decline from its post-IPO highs amid waning consumer demand and intense competition.
  • Management is executing a turnaround strategy focused on significant cost reductions, operational streamlining, and product innovation aimed at improving health credentials (e.g., the Beyond IV platform with avocado oil). The goal is to achieve positive cash flow and improved gross margins.
  • The competitive landscape is fierce, with direct competitor Impossible Foods, traditional meat producers like Tyson and Nestlé entering the space, and numerous other plant-based brands. Beyond Meat‘s premium pricing is a significant disadvantage in an inflationary environment where consumers are price-sensitive.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


How Apyron’s Neurostimulation Solution Breaks the Chronic Pain Barrier

By Water Tower Research

  • Meet the CEO. Jagi Gill began his career as an Assistant Professor of Neurology at Mayo Clinic, embracing two principles that guide him today: relentless innovation and putting patients first.
  • He later joined Boston Scientific, gaining experience in neurostimulation, and Advanced Bionics, where he discovered the energy of startups. 
  • He went on to found Tenex Health, a pioneer in tendon pain treatment, before returning to neurostimulation as founder and CEO of Apyron.

CSAI: WTR Small-Cap Spotlight Recap – AI Comes to Video Surveillance; See More, Act Faster

By Water Tower Research

  • Proactive AI plus human intervention is the core differentiator. Compared with legacy configurations that primarily capture and display video, Cloudastructure’s cloud-based AI reviews site activity continuously, filters signal from noise, and escalates actionable events to trained remote guards who “talk down” intruders via integrated speakers, supporting a reported ~98% deterrence rate.
  • Scale drives efficiency and coverage quality.
  • The platform processes ~8 million videos daily. AI triage lets each guard monitor 50-70 camera feeds versus ~10 for traditional setups, improving response times and eliminating gaps from fatigue or shift changes.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars